Grant Search

Cancer Type

Keyword Search  

Categories

Grant Amount
>=

<=





Results: 152

Pilot Trial to Evaluate the Feasibility and Clinical Utility of ...

Abstract: Outcomes in children with solid tumors that are already spread at the time of diagnosis or that do not respond with chemotherapy are generally poor and attempts to intensify treatment have not improved survival.  Personalized medicine is an emerging field of medicine that uses genetic information obtained from ...

Exploring the brain-gut-microbiota axis to characterize and predict outcome in ...

Abstract Diffuse intrinsic pontine gliomas (DIPGs), represent a group of malignancies with rapid onset of devastating neurologic symptoms associated with the local extension, poor response to adjuvant therapy and a very poor prognosis. Radiotherapy has remained the only modality of treatment with proven transient symptomatic improvement and represents the mainstay ...

Enhancing response to radiation therapy by increasing tumor oxygenation in ...

The survival time for patients with pediatric high-grade glioma (pHGG) remains devastatingly short, in large part because pHGG tumors become resistant to radiation, the only available therapy with confirmed efficacy. This radioresistance is triggered by regions of hypoxia (low oxygen) that develop within the tumor as it grows. We found ...

Development of new nano-platforms for the treatment of triple negative ...

Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer. TNBC lacks the expression of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2) according to immunohistochemistry (IHC). TNBC is characterized by aggressive nature, high metastatic ability, lack of targeted therapy and high mortality ...

Modulating the DIPG microenvironment with virus and complement inhibitors as ...

Diffuse intrinsic pontine glioma (DIPG) is one of the most formidable challenges faced by pediatric oncologists. For the last 30 years, all treatment approaches for these type of tumors have failed, leaving a terrible prospect of survival at 5 years for these children virtually of zero. Thus, it is clear that new ...